HENDERSON, Nev. – April 22, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss first quarter 2025 earnings at 5:00 p.m. ET on Thursday, May 8, 2025. Participant details are as follows: U.S. dial-in: 800.579.2543… Read more »
Paysign is excited to once again be a sponsor at the Plasma Protein Therapeutics Association 2025 International Plasma Protein Congress held on May 20-21 in Warsaw, Poland. This conference will explore the plasma industry, the need to increase plasma collection, patient health, safety, and the developments within regulatory and policy categories.
HENDERSON, Nev. – April 9, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced its CFO, Jeff Baker, will be attending and presenting at the Ladenburg Thalmann Technology Innovation EXPO25 in New York City on… Read more »
Paysign will be a sponsor at the annual Innovative Payments Conference, “Making Sense of Payments in a Changing World” in Washington, D.C. on April 29 – May 01, 2025. This 3-day conference will consist of revolutionary content, discussions, and networking opportunities with those leading the way in payments compliance, legislation, regulation, and innovation.
Paysign will be a supporting sponsor at the upcoming Pharmaceutical Compliance Congress in McLean, VA on April 28-30, 2025. This 3-day conference will consist of hundreds of professionals that will take part in compelling discussions on the most pressing topics affecting compliance programs and operations.
HENDERSON, Nev. – March 25, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the fourth quarter and full-year 2024. “2024 marked another year of outstanding growth and strategic advancement for Paysign,… Read more »
Paysign will be attending the 2025 Asembia Specialty Pharmacy Summit, taking place April 27-May 01, in Las Vegas. The Patient Affordability team will be hosting cocktail style gatherings, as well as one-on-one meetings with interested clients throughout the week. To get in touch or book a meeting with the PA team, email affordability@paysign.com or visit… Read more »
HENDERSON, Nev. – February 27, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss fourth quarter and full year 2024 earnings at 5:00 p.m. ET on Tuesday, March 25, 2025. Participant details are as follows:… Read more »
Paysign is excited to be a supporting sponsor at the ACCESS USA event, Accelerating Access, Partnerships and Collaboration to Deliver Superior Patient Outcomes, in Philadelphia, PA on March 18-20, 2025. Our Patient Affordability team will be there, sharing insights on patient access, drug pricing, copay accumulators, and the continued need for transparency within and throughout the… Read more »
Proprietary Feature Demonstrates Advanced Accuracy in Mitigating Copay Maximizers HENDERSON, Nev. – February 4, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of pharmaceutical copay programs leveraging their patient affordability solutions. Paysign’s dynamic… Read more »
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.